These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8309597

  • 1. HIV or zidovudine myopathy?
    Gherardi R, Chariot P.
    Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
    [No Abstract] [Full Text] [Related]

  • 2. HIV or zidovudine myopathy?
    Dalakas M.
    Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
    [No Abstract] [Full Text] [Related]

  • 3. HIV or zidovudine myopathy?
    Grau JM, Casademont J.
    Neurology; 1994 Feb; 44(2):361; author reply 362-4. PubMed ID: 8309595
    [No Abstract] [Full Text] [Related]

  • 4. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA- and nuclear DNA-encoded subunits.
    Yerroum M, Pham-Dang C, Authier FJ, Monnet I, Gherardi R, Chariot P.
    Acta Neuropathol; 2000 Jul; 100(1):82-6. PubMed ID: 10912924
    [Abstract] [Full Text] [Related]

  • 5. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
    Lane RJ, McLean KA, Moss J, Woodrow DF.
    Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
    [Abstract] [Full Text] [Related]

  • 6. Cytochrome c oxidase deficiency in zidovudine myopathy affects perifascicular muscle fibres and arterial smooth muscle cells.
    Chariot P, Le Maguet F, Authier FJ, Labes D, Poron F, Gherardi R.
    Neuropathol Appl Neurobiol; 1995 Dec; 21(6):540-7. PubMed ID: 8745244
    [Abstract] [Full Text] [Related]

  • 7. Expression of cytochrome c oxidase subunits encoded by mitochondrial or nuclear DNA in the muscle of patients with zidovudine myopathy.
    Chariot P, Bonne G, Authier FJ, Marsac C, Gherardi R.
    J Neurol Sci; 1994 Sep; 125(2):190-3. PubMed ID: 7807166
    [Abstract] [Full Text] [Related]

  • 8. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P, Monnet I, Gherardi R.
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [Abstract] [Full Text] [Related]

  • 9. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
    Pezeshkpour G, Illa I, Dalakas MC.
    Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
    [Abstract] [Full Text] [Related]

  • 10. Zidovudine-associated myopathy.
    Paradis J, Calis KA.
    Am J Hosp Pharm; 1994 Dec 15; 51(24):3026-8. PubMed ID: 7856620
    [No Abstract] [Full Text] [Related]

  • 11. AZT-induced mitochondrial myopathy.
    Tomelleri G, Tonin P, Spadaro M, Tilia G, Orrico D, Barelli A, Bonetti B, Monaco S, Salviati A, Morocutti C.
    Ital J Neurol Sci; 1992 Dec 15; 13(9):723-8. PubMed ID: 1336487
    [Abstract] [Full Text] [Related]

  • 12. HIV or zidovudine myopathy?
    Kieburtz K.
    Neurology; 1994 Feb 15; 44(2):361; author reply 362-4. PubMed ID: 8309596
    [No Abstract] [Full Text] [Related]

  • 13. Prognosis in AZT myopathy.
    Chalmers AC, Greco CM, Miller RG.
    Neurology; 1991 Aug 15; 41(8):1181-4. PubMed ID: 1714057
    [Abstract] [Full Text] [Related]

  • 14. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
    Grau JM, Masanés F, Pedrol E, Casademont J, Fernández-Solá J, Urbano-Márquez A.
    Ann Neurol; 1993 Aug 15; 34(2):206-11. PubMed ID: 8338345
    [Abstract] [Full Text] [Related]

  • 15. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, Roullet E, Gherardi R.
    Ann Neurol; 1991 Jun 15; 29(6):606-14. PubMed ID: 1892364
    [Abstract] [Full Text] [Related]

  • 16. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK.
    Neuropathol Appl Neurobiol; 1994 Jun 15; 20(3):232-7. PubMed ID: 7936072
    [Abstract] [Full Text] [Related]

  • 17. [Muscular involvement in HIV infection].
    Gherardi R, Chariot P, Authier FJ.
    Rev Neurol (Paris); 1995 Nov 15; 151(11):603-7. PubMed ID: 8745623
    [Abstract] [Full Text] [Related]

  • 18. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC, Barker SM, Mitchell DH, Stevens SM, O'Neill P, Cunningham AL.
    Pathology; 1992 Apr 15; 24(2):109-11. PubMed ID: 1641255
    [Abstract] [Full Text] [Related]

  • 19. Turns-amplitude analysis assessment of myopathies in HIV-infected patients.
    Lefaucheur JP, Verroust J, Gherardi RK.
    J Neurol Sci; 1996 Mar 15; 136(1-2):148-53. PubMed ID: 8815162
    [Abstract] [Full Text] [Related]

  • 20. Mitochondrial myopathy caused by long-term zidovudine therapy.
    Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL.
    N Engl J Med; 1990 Apr 19; 322(16):1098-105. PubMed ID: 2320079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.